Characterization of Kaposi's Sarcoma-Associated Herpesvirus-Related Lymphomas by DNA Microarray Analysis
Author(s) -
Keiji Ueda,
Eriko Ohsaki,
Kazushi Nakano,
Xin Zheng
Publication year - 2011
Publication title -
leukemia research and treatment
Language(s) - English
Resource type - Journals
eISSN - 2090-3219
pISSN - 2090-3227
DOI - 10.4061/2011/726964
Subject(s) - primary effusion lymphoma , lymphoma , biology , carcinogenesis , virology , kaposi's sarcoma associated herpesvirus , virus , sarcoma , gene , herpesviridae , cancer research , immunology , viral disease , pathology , medicine , genetics
Among herpesviruses, γ -herpesviruses are supposed to have typical oncogenic activities. Two human γ -herpesviruses, Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), are putative etiologic agents for Burkitt lymphoma, nasopharyngeal carcinoma, and some cases of gastric cancers, and Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma (PEL) especially in AIDS setting for the latter case, respectively. Since such two viruses mentioned above are highly species specific, it has been quite difficult to prove their oncogenic activities in animal models. Nevertheless, the viral oncogenesis is epidemiologically and/or in vitro experimentally evident. This time, we investigated gene expression profiles of KSHV-oriented lymphoma cell lines, EBV-oriented lymphoma cell lines, and T-cell leukemia cell lines. Both KSHV and EBV cause a B-cell-originated lymphoma, but the gene expression profiles were typically classified. Furthermore, KSHV could govern gene expression profiles, although PELs are usually coinfected with KSHV and EBV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom